Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATTNYSE:SDRNYSE:STJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/ASDRSandRidge Mississippian Trust II$0.13$0.20▼$1.12$6.37M1.14172,872 shs434,700 shsSTJSt Jude Medical$80.82$0.00$48.83▼$84.00N/AN/A8.54 million shsN/A7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%SDRSandRidge Mississippian Trust II0.00%0.00%0.00%0.00%0.00%STJSt Jude Medical0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust IIN/AN/AN/AN/AN/AN/AN/AN/ASTJSt Jude MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/ASDRSandRidge Mississippian Trust II 0.00N/AN/AN/ASTJSt Jude Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$14.64M0.00N/A1.11$0.85 per share0.00STJSt Jude MedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$10.32MN/A1.28N/AN/A66.85%21.99%21.99%N/ASTJSt Jude MedicalN/A$5.8713.77∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$0.0522.12%N/AN/AN/ASTJSt Jude Medical$1.241.53%N/A21.12%N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/ASDRSandRidge Mississippian Trust II0.98%STJSt Jude Medical82.73%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/ASDRSandRidge Mississippian Trust IIN/ASTJSt Jude Medical4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableSDRSandRidge Mississippian Trust IIN/A49.73 millionN/AOptionableSTJSt Jude MedicalN/AN/AN/AOptionableATT, STJ, MNG, and SDR HeadlinesRecent News About These CompaniesSt. Jude begins interior buildout of new 15-story outpatient clinic buildingMay 28, 2025 | bizjournals.com'It's just amazing what they do': St. Jude treats the entire family, not just the patientMay 21, 2025 | msn.comHow St. Jude’s medical social workers help parents navigate child’s diagnosisMay 15, 2025 | msn.comFamily shares experience at St. Jude Children’s Research HospitalMay 10, 2025 | wbko.comFighting Sickle Cell: How St. Jude and Donors Gave Avery a New Lease on LifeApril 29, 2025 | msn.comOne Step at a Time: How St. Jude and Supporters Helped Arielle Walk AgainApril 29, 2025 | msn.comSt. Jude Rock and Roll Music City marathon marks 25th anniversary this weekendApril 26, 2025 | newschannel5.comTopeka Dream Home helps St. Jude patients across the U.S.April 24, 2025 | msn.comLocal companies donate materials, labor for St. Jude Dream Home GivewayMarch 28, 2025 | msn.comA St. Jude superhero—this doctor has dedicated her life to treating cancer patientsMarch 22, 2025 | msn.comLocal representative fighting for St. Jude medical care in CharlestonMarch 18, 2025 | msn.com'St. Jude for pets': Decatur vet launching nonprofit research hospital to study diseases affecting humans and animalsMarch 12, 2025 | msn.comSt. Jude, UT, Vanderbilt push to keep NIH fundingFebruary 20, 2025 | dailymemphian.comProposed federal-funding cuts could come at a cost for St. Jude, UTHSCFebruary 12, 2025 | dailymemphian.comCould NIH funding cut affect St. Jude Children's Research Hospital? Here's what we knowFebruary 11, 2025 | msn.comNIH cuts could hurt research at St. Jude, UTFebruary 11, 2025 | msn.comSt. Jude creates new leadership roleJanuary 24, 2025 | beckershospitalreview.comEvidence still under review for suspects in 2023 shooting death of St. Jude doctorJanuary 16, 2025 | wreg.comOklahoma Family Bakes For A Cause To Help St. Jude Children's HospitalDecember 24, 2024 | newson6.comSt. Jude names executive vice president and chief administrative officerDecember 11, 2024 | msn.comTop HeadlinesView All HeadlinesAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in Value3 High-Paying Dividend Stocks That Still Have Safe PayoutsBy Chris Markoch | May 27, 2025View 3 High-Paying Dividend Stocks That Still Have Safe PayoutsThese 3 Stocks Could Be Back in Play Before You Know ItBy Gabriel Osorio-Mazilli | June 10, 2025View These 3 Stocks Could Be Back in Play Before You Know ItHormel Stock Near Lows, But Tariff Relief Could Boost OutlookBy Chris Markoch | May 29, 2025View Hormel Stock Near Lows, But Tariff Relief Could Boost OutlookAlibaba’s Dip Is a Gift—Here’s the Price That MattersBy Gabriel Osorio-Mazilli | June 12, 2025View Alibaba’s Dip Is a Gift—Here’s the Price That MattersATT, STJ, MNG, and SDR Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.SandRidge Mississippian Trust II NYSE:SDRSandRidge Mississippian Trust II holds royalty interests in oil and natural gas properties. The company's properties are located in the Mississippian formation in Alfalfa, Grant, Kay, Noble, and Woods counties in northern Oklahoma and Barber; and Comanche, Harper, and Sumner counties in southern Kansas. As of December 31, 2018, its properties consisted of royalty interests in the initial wells and 173 additional wells. The company was founded in 2011 and is based in Houston, Texas.St Jude Medical NYSE:STJSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Chime’s Smart IPO: Half the Valuation, Double the Strength Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Tesla Bulls and Bears Collide: What Investors Should Know Qualcomm: A Technical Setup Is Emerging, and It's Bullish Why Amazon Could Be About To Breakout To $250 330% Returns YTD: Is CoreWeave's Momentum Softening? Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
